Portfolio

Our portfolio companies are developing important therapies for unmet medical needs. Our deep network of leading academic and industry executives helps generate some of the most promising healthcare deals led by top entrepreneurs.

Be Bio is developing a proprietary class of engineered B cells as medicines that unleash the potential of cell therapies in applications beyond cytotoxicity.

Learn More VISIT SITE

The human approach to oncology

Learn More Visit Site

Developing cancer immunotherapeutics based on new insights into the tumor microenvironment

Learn More Visit Site

Antibody therapeutics addressing serious unmet medical needs

Learn More Visit Site

Developing transformative immuno-stimulatory medicines to unleash a powerful attack on cancer

Learn More Vsit Site

Developing novel T cell therapeutics in cancer

Learn More Visit Site

Addressing the bottlenecks associated with next generation sequencing in translational research by offering a robust platform for targeted sequencing applications

Learn More Visit Site

Manipulating metabolism to develop disease modifying therapeutics for immuno-oncology and immuno-inflammation

Learn More Visit Site

Developing a new class of medicines to treat cancer & other debilitating diseases

Learn More Visit Site

Seeking to detect cancer early, when it can be cured

Learn More Visit Site

Modulating RNA function by targeting regulatory proteins

Learn More Visit Site

Developing the leading range of first-in-class inhaled anti-infectives for targeted treatment of life-threatening lung infections

Learn More Visit Site

Discovering and delivering innovative medical solutions and technology combined with digital health to help individuals suffering from pelvic floor disorders

Learn More Visit Site

Harnessing the link between the human gut microbiome and the central nervous system to develop a new class of therapeutics to improve the quality of life for people with CNS diseases and disorders.

Learn More Visit Site

Easing the burden of patients with severe endocrine disorders

Learn More Visit Site

Bringing innovation to the delivery of women’s healthcare

Learn More Visit Site

A novel innovation for Aesthetic Medicine

Learn More Visit Site

Creating a new generation of small molecule protease inhibitors

Learn More Visit Site

The leading dermatologist-recommended skin health cosmetics company

Learn More Visit Site

Developing oncology therapeutics that inhibit pathways critical to tumor growth and survival

Learn More Visit Site

Discovering and developing therapeutics that enhance mitochondrial functions

Learn More Visit Site

Minimally invasive solutions for the treatment of bone fractures

Learn More Visit Site

Developing therapies to improve the lives of patients diagnosed with cancer in ways that are truly meaningful

Learn More Visit Site

Focused on the discovery, development, and commercialization of proprietary small-molecule drugs

Learn More Visit Site

Improving nutritional status and pill burden in patients with pancreatic diseases

Learn More

Be Biopharma

Be Bio is a leader in developing engineered B cells as a new category of cellular medicines. B cells are one of the most unique and versatile populations of cells in the body, playing a key role in humoral immunity and in modulating immune cell behavior in tumors and chronically inflamed tissues. They are among the human body’s most prolific secreted protein factories, they traffic to tissues in a targetable fashion, and they can engraft in niches for as long as decades.

Read More Visit Site